July 13, 2026
In a recent bylined article for Pharmaceutical Executive, Kirsten Whipple, Executive Vice President, Consumer Wellness at GCI Health, explores a profound shift in consumer expectations: the transition from prioritizing lifespan (how long we live) to healthspan (how long we live free of chronic disease). Drawing on GCI Health’s proprietary research study, “From Live Long to Live Well: The New Healthy Aging Paradigm,” she shares how this evolution is upending traditional healthy aging targeting and messaging and argues that pharma companies must evolve from passive disease managers into proactive lifestyle partners.
In the article, Whipple notes that healthspan has emerged from obscure academic jargon as a potent consumer driver, which is redefining pharma’s role in the aging process. She shares a clear blueprint to help companies optimize opportunities in healthy aging, shifting from a focus on extending lifespan to optimizing quality of life to keep pace with shifting consumer demands.
Read the full article in Pharmaceutical Executive here.